NovaBridge Biosciences (NBP) Other Non-Current Assets (2018 - 2025)

NovaBridge Biosciences (NBP) has 8 years of Other Non-Current Assets data on file, last reported at $2.8 million in Q4 2025.

• Other Non-Current Assets for Q4 2025 came in at $2.8 million, up 106.01% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.8 million (up 106.01% YoY), and the FY2025 annual result was $2.8 million, up 106.01% from the prior year.
• Other Non-Current Assets grew to $2.8 million in Q4 2025 per NBP's latest filing, from $1.1 million in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $4.2 billion in Q4 2021 and troughed at $464000.0 in Q2 2024.
• A 5-year average of $321.8 million and a median of $1.3 million in 2025 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2021 and 2022: Other Non-Current Assets soared 1373416.16% in 2021, then tumbled 99.92% in 2022.
• A 5-year view of Other Non-Current Assets shows it stood at $4.2 billion in 2021, then slumped by 99.92% to $3.5 million in 2022, then tumbled by 83.08% to $594715.8 in 2023, then surged by 129.52% to $1.4 million in 2024, then surged by 106.01% to $2.8 million in 2025.
• Business Quant data shows NBP's Other Non-Current Assets at $2.8 million in Q4 2025, $1.1 million in Q3 2025, and $1.2 million in Q2 2025.